Researchers at the University of Toronto say they have successfully tested the use of machine learning models to guide the design of long-acting injectable drug formulations.

Major players in the drug formulation market are AstraZeneca PLC, The Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., AbbVie ...

This article previews some formulation topics discussed in the Pharma Fundamentals series, which aims to enhance learning for professionals in pharmaceutical drug development and manufacturing.

XORTX Therapeutics Inc. (NASDAQ: XRTX | TSXV: XRTX | FSE: ANU), a late-stage clinical pharmaceutical company, pivoted to ...

This comprehensive overview of contemporary formulation strategies covers the drug product lifecycle from end to end, illustrating best practices for various formulation types seen through a CRDMO’s ...

DS characterization is critical to DP formulation but characterization and formulation are often not integrated during drug development. This creates needless difficulties because if DS chemists ...

As a result, companies often settle for suboptimal formulations that fail to maximize a drug’s performance, leaving most of the design space untapped. Intrepid Labs is transforming drug formulation ...

While the approval of Leqembi Iqlik bodes well for Biogen and Eisai’s planned application for a subcutaneous induction ...

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that ultra-long-acting subcutaneous (SQ) depot maintenance formulation of small molecule GLP-1 receptor (GLP-1R) agonist ASC30 ...

DUBLIN--(BUSINESS WIRE)--The "Deuterated Drugs Formulations Therapeutics Markets Strategies" report has been added to Research and Markets' offering. Deuterated Drugs: Products, Pipelines ...